(15) found that patients with COVID-19 had lower numbers of CD4 T lymphocytes specific against Mtb compared with patients without COVID-19, which could mean that cellular defense against Mtb is decreased with SARS-CoV-2 coinfection. This evidence concerns the gene CD4 and COVID-19.